ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2016
No Target Left Behind: Improving Therapeutic Options for ERBB2-Mutant Non-Small Cell Lung Cancer.
Amanda J Redig et al.PubMed ↗Publisher ↗
No numbers read from the abstract.